Wepox 10000 iu

Name: Wepox 10000 iu
Brand: Ezan Pharmaceuticals
Price: 900 INR
Availability: InStock

Price 900 INR/ Unit

Get a Price/Quote

MOQ : 10 Packs

Wepox 10000 iu Specification

Brand Name
Erypro Safe

Dosage Form
Injection

Salt Composition
Erythropoietin Alfa

Life Span
24 months from the date of manufacture

Origin of Medicine
India

Indication
Anemia due to chronic kidney disease, chemotherapy, and zidovudine-treated HIV infection

Packaging Type
Pre-filled syringe in box

Pacakaging (Quantity Per Box)
1 syringe per box

Drug Type
Other

Ingredients
Erythropoietin (Recombinant Human Erythropoietin Alfa)

Physical Form
Liquid

Function
Other

Recommended For
Treatment of anemia associated with chronic renal failure, cancer chemotherapy, HIV infection and certain other conditions

Dosage
As directed by physician; common dosage is 4000 IU/ml

Dosage Guidelines
Administered as per physicians instructions subcutaneously or intravenously

Suitable For
Suitable For All

Quantity
1 Pre-filled syringe

Storage Instructions
Store at 2C to 8C. Do not freeze. Protect from light.

Regulatory Approval
Manufactured under GMP and Indian Pharmacopeia (IP) standards

Strength
4000 IU/ml

Adverse Effects
Hypertension, headache, joint pains, injection site reactions

pH Range
Approximately 6.8 - 7.4

Precautions
Monitor hemoglobin and blood pressure levels

Molecular Weight
30.4 kDa (protein)

Preservation
Single-use only, discard any unused portion

Contraindications
Known hypersensitivity to mammalian cell-derived products or to any of the excipients

Colour
Colourless to pale yellow

Administration Route
Intravenous or subcutaneous

Wepox 10000 iu Trade Information

Minimum Order Quantity
10 Packs

Payment Terms
Cash in Advance (CID)

Supply Ability
5000 Packs Per Month

Delivery Time
10 Days

Main Domestic Market
All India, Tripura, Mizoram, Meghalaya, Manipur, Arunachal Pradesh, Nagaland, Assam

About Wepox 10000 iu

Erypro Safe, a top-drawer Erythropoietin Injection IP (4000 IU/ml), is currently in demand among healthcare professionals seeking sublime management for anemia linked with chronic kidney disease, chemotherapy, or HIV-related treatments. This protein-based, colourless to pale yellow liquid is administered intravenously or subcutaneously, ensuring majestic results through advanced GMP manufacturing in India. Capitalise on its superior single-use design and exceptional safety, as each pre-filled syringe is engineered for optimal performance and remarkable patient outcomes during promotional and routine clinical protocols.

Versatile Usage and Key Application Areas

Erythropoietin Injection IP demonstrates its versatility through its dual administration route-intravenous or subcutaneous-making it suitable for various clinical settings. Used as a potent treatment for anemia, it is implemented across hospitals, dialysis centers, cancer clinics, and specialty healthcare institutions. Trusted by physicians, it is recommended for both adults and children. Its application extends to addressing anemia connected to chronic kidney failure, cancer chemotherapy, and HIV infection-associated conditions, offering patients an elevated standard of care.

Certifications, Sample Access, and Logistics

Erypro Safe is manufactured under strict GMP and Indian Pharmacopeia (IP) certification, guaranteeing product quality and consistency. Shipped from leading Indian FOB ports, it reaches suppliers and traders promptly via reliable transport services. Samples are available under a defined sample policy to ensure customer confidence prior to large-scale purchases. Drop-off and handling procedures are meticulously followed, ensuring the integrity of the medicine throughout the shipping and delivery process. Trust our seamless logistics for your medical supply needs.

FAQ's of Erythropoietin Injection IP:

Q: How should Erythropoietin Injection IP be administered for maximum effectiveness?

A: Erythropoietin Injection IP should be given either intravenously or subcutaneously, strictly following your physician's guidance for dosage and frequency. Regular monitoring of hemoglobin and blood pressure is recommended to ensure safety and efficacy.

Q: What precautions need to be observed while using Erypro Safe?

A: It is crucial to monitor hemoglobin and blood pressure levels regularly, as adverse effects such as hypertension, headache, or joint pain may occur. Additionally, Erypro Safe is contraindicated in patients with known hypersensitivity to mammalian cell-derived products or its excipients.

Q: Where can Erythropoietin Injection IP be used and who can benefit from it?

A: This injection is primarily used in hospitals, dialysis units, cancer clinics, and specialty medical centers. Adults and children suffering from anemia due to chronic kidney disease, chemotherapy, or HIV infection may benefit from Erypro Safe.

Q: What is the storage guideline for Erythropoietin Injection IP?

A: Erythropoietin Injection IP should be kept refrigerated at 2C to 8C, protected from light, and must never be frozen. It should be used once and any unused portion discarded immediately to maintain safety.

Q: When is Erypro Safe recommended and what is its main function?

A: Erypro Safe is recommended for treating anemia in patients with chronic kidney disease, those undergoing chemotherapy, or receiving zidovudine for HIV. Its main function is to stimulate red blood cell production and thereby improve anemia-related symptoms.

Tell us about your requirement